Dr Reddys Laboratories (RDY) Non-Current Deferred Tax Liability (2009 - 2026)
Dr Reddys Laboratories' Non-Current Deferred Tax Liability was $171.19 million in the quarter ended Jun 30, 2026, up 1.4% from $168.84 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Non-Current Deferred Tax Liability at Dr Reddys Laboratories came in at $166 million, up 0.6% from the prior year.
- Non-Current Deferred Tax Liability shows a five-year compound annual growth rate of 101.5% (years ended Mar 2021 to Mar 2026).
- In earlier years, Non-Current Deferred Tax Liability was $165 million in the year ended Mar 31, 2025, $11 million in the year ended Mar 31, 2024 (+10.0%), $10 million in the year ended Mar 31, 2023 (+900.0%) and $1 million in the year ended Mar 31, 2022 (-80.0%).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Non-Current Deferred Tax Liability in data going back to the quarter ended Mar 31, 2009.
- Compared with a year earlier, Non-Current Deferred Tax Liability has increased for five straight quarters, with growth averaging 40.8% over the last five quarters.
- The best year-over-year quarter for Non-Current Deferred Tax Liability over five years was the quarter ended Jun 30, 2023 (growth of 995.6%); the worst was the quarter ended Mar 31, 2022 (a decline of 82.8%).
- Per Business Quant data, RDY's Non-Current Deferred Tax Liability in the three quarters before the quarter ended Jun 30, 2026 was $170.3 million (quarter ended Mar 31, 2026), $165.92 million (quarter ended Dec 31, 2025) and $169.99 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Dr Reddys Laboratories | 11.03 Bn | 10.40 Bn | 396.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 170.98 Mn |
| Mar 31, 2026 | 164.99 Mn |
| Dec 31, 2025 | 164.59 Mn |
| Sep 30, 2025 | 167.15 Mn |
| Jun 30, 2025 | 169.09 Mn |
| Mar 31, 2025 | 164.93 Mn |
| Dec 31, 2024 | 162.01 Mn |
| Sep 30, 2024 | 165.20 Mn |
| Jun 30, 2024 | 57.34 Mn |
| Mar 31, 2024 | 10.90 Mn |
| Dec 31, 2023 | 12.02 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 7.82 Mn |
| Mar 31, 2023 | 10.15 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | 564,551.56 |
| Jun 30, 2022 | 697,099.92 |
| Mar 31, 2022 | 791,266.58 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.33 Mn |
API Access
Dr Reddys Laboratories Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();